Metabolic

Tesamorelin

Research ordering doesn't need to feel complicated. Tesamorelin 40mg comes in a convenient Peptide Pen, with the key product information upfront. Purita keeps the focus on quality, clarity and an easy buying experience.

€219.90 · 40mg

Available options

• 10mg
• 40mg

Product information

What it is Tesamorelin is a modified form of Growth Hormone Releasing Hormone (GHRH). The molecule retains the 44-amino-acid sequence of human GHRH, but a structural modification helps protect it from rapid enzymatic breakdown. Its activity starts at GHRH receptors in the pituitary gland. Activation of these receptors promotes the release of the body's own growth hormone, which in turn affects downstream IGF-1 levels. How it works and what the research shows Human research on Tesamorelin has largely focused on adults with HIV-associated abdominal fat accumulation. In clinical trials, researchers observed reductions in visceral adipose tissue along with higher IGF-1 levels. Some lipid measures changed as well. These findings come from defined clinical populations. Research in other settings shouldn't be assumed to produce the same results, particularly where the available evidence is more limited. Tesamorelin 40mg Peptide Pen The 40mg pen provides a larger total amount of pre-formulated Tesamorelin in a ready-prepared format. No separate reconstitution is needed before laboratory research. Commonly Paired With Tesamorelin is primarily studied through the GH/IGF-1 axis, but related metabolic and endocrine research extends well beyond this pathway: SS-31, also known as elamipretide, shifts the focus to mitochondrial function, cardiolipin and cellular responses to stress.  Ela